Signup Crypto ETF Stocks News

EnviroGold Global Engages Hatch to Advance Commercialisation of NVRO Process™ - EnviroGold Global ( OTC:ESGLF )

TORONTO, June 11, 2025 ( GLOBE NEWSWIRE ) -- EnviroGold Global Limited NVROESGLFYTK ) , ( "EnviroGold," or the "Company" ) , a clean technology company focused on reprocessing mine waste to recover precious, base, and critical metals, is pleased to announce the appointment of Hatch Pty Ltd. ( ...

Source: www.benzinga.com
June 11, 2025 | 11:04:00
Category: General

Boosting Social Security: A Simple Way to Increase the Average Payment Up to $1,000

Your monthly Social Security benefit is based primarily on your career earnings and when you claim benefits. The first one is pretty straightforward: The more you earn over the years, the more you pay in Social Security payroll taxes ( up to a certain amount ) , and the larger you can expect your ...

Source: www.fool.com
June 11, 2025 | 11:18:00
Category: News

EBC Financial Group Launches over a 100 U.S. ETF CFDs, Strengthening Diversification for Global Clients

LONDON, June 11, 2025 ( GLOBE NEWSWIRE ) -- EBC Financial Group ( EBC ) has announced the launch of over 100 new U.S.-listed Exchange-Traded Fund ( ETF ) CFDs, expanding its multi-asset product suite and offering global client's deeper access to diversified, thematic trading opportunities.

Source: www.benzinga.com
June 11, 2025 | 11:19:59
Category: General

Asetek signs new customer agreement for Mainstream Liquid Cooling Products

AALBORG, Denmark, June 11, 2025 /PRNewswire/ -- Asetek is pleased to announce a new customer agreement with Antec, a global leader in high-performance computer components and accessories for the gaming, PC upgrade, and Do-It-Yourself markets.

Source: www.benzinga.com
June 11, 2025 | 11:25:00
Category: General

Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology - Vaxart ( NASDAQ:VXRT )

- Second-generation norovirus constructs produce statistically significant increases in GI.1 and GII.4 norovirus blocking antibodies ( 141% and 94%, respectively ) compared with first-generation constructs, supporting potential for improved protection against infection -

Source: www.benzinga.com
June 11, 2025 | 11:30:00
Category: General

Habit Burger & Grill Celebrates Fifth Restaurant in Virginia with Fredericksburg Launch

New Habit Restaurant To Open Doors On June 18; Hold Pre-Opening VIP Events on June 14, June 16-17

Source: www.benzinga.com
June 11, 2025 | 11:30:00
Category: General

Bitdeer Announces May 2025 Production and Operations Update - Bitdeer Technologies ( NASDAQ:BTDR )

- Increased self-mining hashrate to 13.6 EH/s on continued deployment of SEALMINERs - Sold and shipped 1.6 EH/s of SEALMINER A2s to external customers

Source: www.benzinga.com
June 11, 2025 | 11:30:00
Category: General

BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder ( MDD ) - BrainsWay ( NASDAQ:BWAY )

BURLINGTON, Mass. and JERUSALEM, June 11, 2025 ( GLOBE NEWSWIRE ) -- BrainsWay Ltd. ( NASDAQ & TASE: BWAY ) , a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced preliminary results from a multicenter, randomized controlled trial ...

Source: www.benzinga.com
June 11, 2025 | 11:30:00
Category: General

China grants export permits to rare earth giant for US, Europe shipments

A top Chinese rare earth exporter, which hosted President Xi Jinping during a 2019 inspection, said it had obtained export permits for several destinations, including the United States. Investors welcomed the news, sending the company's shares higher.

Source: www.scmp.com
June 11, 2025 | 11:30:07
Category: Economy

EXCLUSIVE: Adial Pharmaceuticals Lead Candidate For Alcohol Use Disorder Advances Toward Phase 3 Trial - Adial Pharmaceuticals ( NASDAQ:ADIL )

Adial's Phase 3 trial for AD04 will target genotype-specific subgroups of heavy drinkers with Alcohol Use Disorder. The trial is expected to launch in late 2025, with interim analyses potentially accelerating regulatory submission.

Source: www.benzinga.com
June 11, 2025 | 11:30:44
Category: General

© Natavest 2025 - 2026